NORD Says Orphan Drug Act Is Fine As Is, Wants To Work For Improvements Within System
This article was originally published in The Pink Sheet Daily
Executive Summary
The group is afraid asking for wholesale changes to the law would invite too many problems, VP Dorman says at BIO.